Evotec SE (EVO) Other Accumulated Expenses (2020 - 2026)
Evotec SE's (EVO) quarterly Other Accumulated Expenses came in at $29067.3 in Q1 2026, down 0.53% year-on-year from $29222.4 in Q1 2025, and up 16.68% quarter-over-quarter from $24911.7 in Q4 2025.
Evotec SE (EVO) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
Evotec SE has disclosed Other Accumulated Expenses across 7 years of filings, most recently posting $29067.3 for Q1 2026.
- Other Accumulated Expenses for Q1 2026 came in at $29067.3, down 0.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $29067.3 (down 0.53% YoY), and the FY2025 annual result was $24911.7, down 15.06% from the prior year.
- Other Accumulated Expenses came in at $29067.3 for Q1 2026 at Evotec SE, up from $24911.7 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $32666.9 in Q3 2025 to a low of $11984.3 in Q1 2022.
- The 5-year median for Other Accumulated Expenses is $27445.3 (2025), against an average of $25113.9.
- Across the five-year window, Other Accumulated Expenses fell 28.48% in 2022 and grew 24.45% in 2025, its largest moves.
- Evotec SE's Other Accumulated Expenses stood at $14781.3 in 2022, then jumped by 64.3% to $24286.1 in 2023, then grew by 20.76% to $29328.7 in 2024, then decreased by 15.06% to $24911.7 in 2025, then grew by 16.68% to $29067.3 in 2026.
- The last three Other Accumulated Expenses figures came in at $29067.3 (Q1 2026), $24911.7 (Q4 2025), and $32666.9 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Evotec SE | 583.10 Mn | 582.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29,067.27 |
| Dec 31, 2025 | 24,911.70 |
| Sep 30, 2025 | 32,666.91 |
| Jun 30, 2025 | 28,641.98 |
| Mar 31, 2025 | 29,222.40 |
| Dec 31, 2024 | 29,328.67 |
| Sep 30, 2024 | 26,248.54 |
| Dec 31, 2023 | 24,286.12 |
| Sep 30, 2022 | 14,781.30 |
| Mar 31, 2022 | 11,984.32 |
| Dec 31, 2021 | 14,367.13 |
| Sep 30, 2021 | 20,668.19 |
| Dec 31, 2020 | 23,897.07 |